Table 1.
Total N (%) | PAI only N (%) | PAI & T1DM N (%) | P | |
---|---|---|---|---|
Total Presentations | 252 | 215 (85.3) | 37 (14.7) | |
Sex | ||||
Female | 174 (69.0) | 148 (68.8) | 26 (70.3) | |
Male | 78 (31.0) | 67 (31.2) | 11 (29.7) | NS |
Age group | ||||
18–29 | 41 (16.3) | 35 (16.3) | 6 (16.2) | |
30–39 | 29 (11.5) | 22 (10.2) | 7 (18.9) | |
40–49 | 36 (14.3) | 35 (16.3) | 1 (2.7) | |
50–59 | 25 (9.9) | 21 (9.8) | 4 (10.8) | |
60–69 | 48 (19.0) | 39 (18.1) | 9 (24.3) | |
70+ | 73 (29.0) | 63 (29.3) | 10 (27.0) | NS |
Ambulance | 122 (48.4) | 94 (43.7) | 28 (75.7) | <0.001 |
AC recorded | 63 (25.0) | 56 (26.0) | 7 (18.9) | NS |
Admissions | 211 (83.7) | 181 (84.2) | 30 (81.1) | NS |
Principal diagnosis | ||||
Infection | 114 (45.2) | 103 (47.9) | 11 (29.7) | <0.05 |
Trauma | 19 (7.5) | 14 (6.5) | 5 (13.5) | <0.05 |
AI | 86 (34.1) | 80 (37.2) | 6 (16.2) | <0.05 |
Gastroenteritis | 31 (12.3) | 31 (14.4) | 0 (0.0) | <0.05 |
Comorbid conditions | ||||
Asthma/COPD | 36 (14.3) | 32 (17.5) | 4 (12.1) | NS |
Cardiovascular disease | 40 (15.9) | 38 (21.5) | 2 (5.7) | <0.05 |
Thyroid | 131 (52.0) | 104 (48.4) | 27 (73.0) | <0.01 |
T2DM | 82 (32.5) | 82 (38.1) | 0 (0.0) | <0.001 |
Management | ||||
Oral stress dosing | 40 (15.9) | 35 (16.3) | 5 (13.5) | NS |
IM stress dosing | 7 (2.8) | 7 (3.3) | 0 (0.0) | NS |
Any stress dosing | 45 (17.9) | 40 (18.6) | 5 (13.5) | NS |
IV hydrocortisone | 185 (73.4) | 162 (75.3) | 23 (62.2) | NS |
Surgical intervention | 14 (5.6) | 9 (4.2) | 5 (13.5) | <0.05 |
DKA recorded | 11 (4.4) | 0 (0.0) | 11 (29.7) | <0.001 |
Mortality | 5 (2.0) | 3 (1.4) | 2 (5.4) | NS |
Abbreviations: COPD, chronic obstructive pulmonary disease; NS, not significant.